Withdrawal of Cyclosporine or Tacrolimus After Addition of Mycophenolate Mofetil in Patients With Chronic Allograft Nephropathy
Open Access
- 1 April 2004
- journal article
- clinical trial
- Published by Elsevier in American Journal of Transplantation
- Vol. 4 (4) , 655-662
- https://doi.org/10.1111/j.1600-6143.2004.00404.x
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-upTransplant International, 2002
- TRANSFORMING GROWTH FACTOR (TGF)-?? MIMICS AND ANTI-TGF-?? ANTIBODY ABROGATES THE IN VIVO EFFECTS OF CYCLOSPORINETransplantation, 1999
- Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in ratsKidney International, 1999
- Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicityKidney International, 1996
- SEQUENTIAL CYTOKINE EXPRESSION IN RENAL ALLOGRAFTS IN RATS IMMUNOSUPPRESSED WITH MAINTENANCE CYCLOSPORINE OR MYCOPHENOLATE MOFETIL1Transplantation, 1996
- REVERSIBILITY OF CHRONIC RENAL ALLOGRAFT REJECTIONTransplantation, 1994
- Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles.Journal of Clinical Investigation, 1993
- ACUTE EFFECTS OF INTRAVENOUS CYCLOSPORINE ON BLOOD PRESSURE, RENAL HEMODYNAMICS, AND URINE PROSTAGLANDIN PRODUCTION OF HEALTHY HUMANSTransplantation, 1990
- CYCLOSPORIN IN THERAPEUTIC DOSES INCREASES RENAL ALLOGRAFT VASCULAR RESISTANCEThe Lancet, 1986
- Remission of Essential Hypertension after Renal TransplantationNew England Journal of Medicine, 1983